Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612687 · ClinicalTrials.gov registry record
Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 20
- Enrollment target
NCT03612687 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants.
The verdict
NCT03612687 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a pilot study with the primary objective to validate the use of advanced minimally invasive hemodynamic monitoring with the PreSep™ Central Venous Oximetry Catheter, the Vigileo™ monitor, and FloTrac™ sensor for perioperative fluid management in Hepatobiliary and Pancreas Surgery. All of these devices and monitors are FDA approved devices and routinely used in the perioperative setting for these cases.
Interventions
- DEVICE Minimally invasive hemodynamic monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-05 |
| Est. Completion | 2014-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03612687
The ClinicalTrials.gov registry entry for NCT03612687 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minimally invasive hemodynamic monitoring is the first listed.
NCT03612687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03612687 about?
NCT03612687 is a clinical study titled "Hemodynamic Monitoring in Hepatopancreaticobiliary (HPB) Surgery". This is a pilot study with the primary objective to validate the use of advanced minimally invasive hemodynamic monitoring with the PreSep™ Central Venous Oximetry Catheter, the Vigileo™ monitor, and FloTrac™ sensor for perioperative fluid management in Hepatobiliary and Pancreas Surgery. All of the...
What is the current status of trial NCT03612687?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2014-05. Estimated completion is 2014-11.
What interventions are being tested in trial NCT03612687?
The interventions under investigation include: Minimally invasive hemodynamic monitoring (DEVICE).
Who is sponsoring clinical trial NCT03612687?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.